133 related articles for article (PubMed ID: 64604)
1. New neonatal problems of blood coagulation and fibrinolysis. I. The change of plasmin inhibitor levels in the newborn infant.
Suzuki S; Wake N; Yoshiaki K
J Perinat Med; 1976; 4(4):213-20. PubMed ID: 64604
[TBL] [Abstract][Full Text] [Related]
2. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
[TBL] [Abstract][Full Text] [Related]
3. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
Aoki N; Moroi M; Matsuda M; Tachiya K
J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
[TBL] [Abstract][Full Text] [Related]
4. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
Harpel PC
J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic disorders and respiratory distress in the newborn.
Boyer C; Ménaché D; Beaufils F; Mathieu H
Intensive Care Med; 1977 Dec; 3(4):273-8. PubMed ID: 73554
[TBL] [Abstract][Full Text] [Related]
6. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: The change of fibrin split products and plasmin-inhibitor in the newborn infant.
Suzuki S
Thromb Diath Haemorrh; 1975 Sep; 34(1):355. PubMed ID: 52903
[No Abstract] [Full Text] [Related]
9. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
Aoki N; Moroi M; Tachiya K
Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
[TBL] [Abstract][Full Text] [Related]
10. Serum inhibitors in fibrinolysis.
Gallimore MJ
Br J Haematol; 1975 Oct; 31(2):217-31. PubMed ID: 53065
[TBL] [Abstract][Full Text] [Related]
11. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.
Booth NA; Bennett B
Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
Sumi H; Takada Y; Takada A
Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
[No Abstract] [Full Text] [Related]
13. Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.
Abe T; Kazama M
Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53895
[No Abstract] [Full Text] [Related]
14. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Ito T; Saito M; Morishita E; Yamazaki M; Suga Y; Miyamoto KI; Nakao S
Blood Coagul Fibrinolysis; 2001 Jun; 12(4):275-81. PubMed ID: 11460011
[TBL] [Abstract][Full Text] [Related]
15. Procoagulant and fibrinolytic activity after polytrauma in rat.
Wu X; Darlington DN; Cap AP
Am J Physiol Regul Integr Comp Physiol; 2016 Feb; 310(4):R323-9. PubMed ID: 26632604
[TBL] [Abstract][Full Text] [Related]
16. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
17. Plasmin inactivation in plasma.
Haselager EM; Goote TM; Vreeken J
Thromb Haemost; 1976 Jun; 35(3):643-50. PubMed ID: 62411
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
19. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
20. The alpha2-plasmin inhibitor levels in liver diseases.
Aoki N; Yamanaka T
Clin Chim Acta; 1978 Mar; 84(1-2):99-105. PubMed ID: 76519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
